| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-01-31 | FY 2023
FILED 2024-01-31 |
|---|---|---|---|
| Revenue (Total Sales) | $512.7M | $531.0M | $553.2M |
| YoY Revenue Growth % | -3.5% | -4.0% | — |
| Gross Profit | $378.0M | $396.1M | — |
| Gross Margin % | 73.7% | 74.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$89.5M | -$69.6M | -$308.6M |
| Operating Margin % | -17.5% | -13.1% | -55.8% |
| Net Income (GAAP) | -$139.8M | -$121.9M | -$349.3M |
| EBITDA (Normalized) | -$88.1M | -$68.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $25.1M | $30.0M | $2.8M |
| Capital Expenditures (CapEx) | $1.8M | $1.6M | — |
| Free Cash Flow (FCF) | $23.3M | $28.4M | $2.8M |
| FCF Margin % | 4.5% | 5.3% | 0.5% |
| Return on Invested Capital (ROIC %) | -15.8% | -9.7% | — |
| Cash & Short-Term Equivalents | $94.1M | $100.8M | — |
| Total Debt (Short + Long Term) | $570.8M | $573.3M | — |
| Total Stockholders' Equity | -$30.2M | $93.8M | — |